Panacea Biotec 
Welcome,         Profile    Billing    Logout  
 1 Product   3 Diseases  1 Product   2 Trials   41 News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mOPV1 (monovalent oral poliovirus vaccine type 1) / Panacea Biotec, Bio Farma Indonesia
NCT05644184: Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

Recruiting
2
2012
RoW
Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1), Sabin Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1)
PATH, Bill and Melinda Gates Foundation, PT Bio Farma, Centers for Disease Control and Prevention, DiagnoSearch Life Sciences Pvt. Ltd.
Poliomyelitis
05/26
05/26
NCT04529538: Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

Completed
1
226
US
Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin Monovalent Oral Polio Vaccine Type 1 (mOPV1), Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3), Sabin monovalent oral polio vaccine type 3
PATH, Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention, Viroclinics Biosciences B.V., The Emmes Company, LLC
Poliomyelitis
02/23
02/23
mOPV1, NCT04504539: Use of in Routine Immunization in Pakistan.

Not yet recruiting
N/A
560
RoW
mOPV, bOPV, Full dose IPV, fractional IPV
Aga Khan University, World Health Organization
Oral Polio Vaccine
05/21
12/21
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
mOPV1 (monovalent oral poliovirus vaccine type 1) / Panacea Biotec, Bio Farma Indonesia
NCT05644184: Study of a Novel Type 1 Oral Poliomyelitis Vaccine in Bangladesh

Recruiting
2
2012
RoW
Novel Live Attenuated Type 1 Oral Poliomyelitis Vaccine (nOPV1), Sabin Monovalent Oral Poliomyelitis Vaccine Type 1 (mOPV1)
PATH, Bill and Melinda Gates Foundation, PT Bio Farma, Centers for Disease Control and Prevention, DiagnoSearch Life Sciences Pvt. Ltd.
Poliomyelitis
05/26
05/26
NCT04529538: Study of Novel Types 1 and 3 Oral Poliomyelitis Vaccines

Completed
1
226
US
Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 3 (nOPV3), Sabin Monovalent Oral Polio Vaccine Type 1 (mOPV1), Sabin Monovalent Oral Polio Vaccine Type 3 (mOPV3), Sabin monovalent oral polio vaccine type 3
PATH, Bill and Melinda Gates Foundation, Centers for Disease Control and Prevention, Viroclinics Biosciences B.V., The Emmes Company, LLC
Poliomyelitis
02/23
02/23
mOPV1, NCT04504539: Use of in Routine Immunization in Pakistan.

Not yet recruiting
N/A
560
RoW
mOPV, bOPV, Full dose IPV, fractional IPV
Aga Khan University, World Health Organization
Oral Polio Vaccine
05/21
12/21

Download Options